InMed Pharmaceuticals Inc.InMed Pharmaceuticals Inc.InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

No trades
See on Supercharts

INM fundamentals

InMed Pharmaceuticals Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of INM for the last quarter is 1.28 M USD, and it's 9.42% higher compared to the previous quarter. The net income of Q4 24 is -1.94 M USD.

Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth